Loading stock data…
UFPT
$221.97-8.58 (-3.72%)
After Hours$221.12-0.85 (-0.38%)· Last close May 11
UFP Technologies, Inc., together with its subsidiaries, designs and manufactures solutions for medical devices, sterile packaging, and other engineered custom products in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
UFP Technologies, Inc. in the Healthcare sector is trading at $221.97. The stock is currently 19% below its 52-week high of $274.93, remaining 2.1% above its 200-day moving average. Technical signals show neutral RSI of 64 and bullish MACD crossover, explaining why UFPT maintains its current momentum and trend strength. The Whystock Score of 70/100 reflects a high-conviction bullish alignment.
Ecosystem Influences
Neutral momentum (RSI 64) — price action in range
Long-term trend bullish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$221.97
Potential Downside
9.1%
Whystock Fair Value$201.77
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus2 analysts
Buy
Mean target$324.50+46.2%
Range$289.00 – $360.00
Fundamentals
UFP Technologies, Inc., together with its subsidiaries, designs and manufactures solutions for medical devices, sterile packaging, and other engineered custom products in the United States. The company provides protective drapes for robotic surgery, ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$1.57B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
23.28
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.17
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
15.83%
Volume
Today's trading volume
220,693
Recent News
UFP Technologies: The Medical Device Maker Hiding Inside an Industrial Stock
Medical sales now represent 92% of UFP Technologies revenue after growing 23% in 2025, yet the market still prices the business as though the industrial past defines the economic future.
UFP Technologies Q1 Earnings Call Highlights
UFP Technologies (NASDAQ:UFPT) reported first-quarter 2026 results that management said reflected a solid start to the year, led by continued growth in its medical business and progress on strategic capacity and program expansion initiatives. Quarterly performance driven by medical growth Chief Exe
UFP Technologies, Inc. Q1 2026 Earnings Call Summary
Moby summary of UFP Technologies, Inc.'s Q1 2026 earnings call
Should UFPT’s MedTech-Led Q1 2026 Earnings Growth Shift How Investors View Its Core Strategy?
UFP Technologies, Inc. has now reported its first-quarter 2026 results, with sales of US$154.2 million and net income of US$17.5 million, reflecting year-on-year increases in both revenue and earnings per share from continuing operations. The results highlight continued momentum in higher-growth MedTech activities, as medical sales rose while non-medical revenue contracted, aligning with the company’s emphasis on specialized medical device manufacturing and capacity expansion. Next, we’ll...
UFP Technologies (UFPT) Tops Q1 Earnings Estimates
UFP (UFPT) delivered earnings and revenue surprises of +13.76% and -2.09%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?